Global Glucose IV Bag Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Glucose IV Bag Market Research Report 2024
A glucose IV bag is a sterile solution. It is used where there has been a lot of water loss from the body and to prevent it. It is used as a solvent and carrier for other compatible drugs for parental administration of medicines.
According to Mr Accuracy reports’s new survey, global Glucose IV Bag market is projected to reach US$ 1011.1 million in 2029, increasing from US$ 812 million in 2022, with the CAGR of 3.2% during the period of 2024 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Glucose IV Bag market research.
The glucose injection bag market is primarily driven by the crucial role it plays in intravenous (IV) therapy, providing a readily available and essential source of glucose for patients in need of rapid energy supplementation. These bags contain sterile glucose solution, widely used for treating hypoglycemia, dehydration, and providing nutritional support in various medical settings. The increasing prevalence of diabetes, critical illnesses, and surgical procedures that require glucose administration fuels the demand for glucose injection bags. However, the market also faces challenges, including the rising concerns about plastic waste and environmental impact associated with single-use medical devices like IV bags. Manufacturers are actively exploring sustainable packaging options and eco-friendly materials to address these environmental challenges. Additionally, fluctuations in the availability and cost of raw materials can impact the production and distribution of glucose injection bags, posing challenges for healthcare facilities in ensuring a stable supply to meet patient needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Glucose IV Bag market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Baxter
Kelun Group
Fresenius Kabi
B Braun
SSY Group
CR Double-Cran
Otsuka
ICU Medical
Cisen Pharmaceutical
Huaren Pharmaceutical
Zhejiang Chimin
Segment by Type
50ml
100ml
500ml
Other
Hospitals
Clinics
Others
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Glucose IV Bag report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source
According to Mr Accuracy reports’s new survey, global Glucose IV Bag market is projected to reach US$ 1011.1 million in 2029, increasing from US$ 812 million in 2022, with the CAGR of 3.2% during the period of 2024 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Glucose IV Bag market research.
The glucose injection bag market is primarily driven by the crucial role it plays in intravenous (IV) therapy, providing a readily available and essential source of glucose for patients in need of rapid energy supplementation. These bags contain sterile glucose solution, widely used for treating hypoglycemia, dehydration, and providing nutritional support in various medical settings. The increasing prevalence of diabetes, critical illnesses, and surgical procedures that require glucose administration fuels the demand for glucose injection bags. However, the market also faces challenges, including the rising concerns about plastic waste and environmental impact associated with single-use medical devices like IV bags. Manufacturers are actively exploring sustainable packaging options and eco-friendly materials to address these environmental challenges. Additionally, fluctuations in the availability and cost of raw materials can impact the production and distribution of glucose injection bags, posing challenges for healthcare facilities in ensuring a stable supply to meet patient needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Glucose IV Bag market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Baxter
Kelun Group
Fresenius Kabi
B Braun
SSY Group
CR Double-Cran
Otsuka
ICU Medical
Cisen Pharmaceutical
Huaren Pharmaceutical
Zhejiang Chimin
Segment by Type
50ml
100ml
500ml
Other
Segment by Application
Hospitals
Clinics
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Glucose IV Bag report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source